These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 38578157

  • 1. HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway.
    Wang J, Yang K, Yang X, Jin T, Tian Y, Dai C, Xu F.
    Mol Carcinog; 2024 Jul; 63(7):1275-1287. PubMed ID: 38578157
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X, Wen H, Jing L, Yang Y, Wang W, Liang X, Nan K, Yao Y, Tian T.
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [Abstract] [Full Text] [Related]

  • 3. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.
    Zhang M, Liu S, Chua MS, Li H, Luo D, Wang S, Zhang S, Han B, Sun C.
    Cell Death Dis; 2019 Aug 13; 10(8):612. PubMed ID: 31406106
    [Abstract] [Full Text] [Related]

  • 4. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
    Wu L, Zheng J, Chen P, Liu Q, Yuan Y.
    Biomed Pharmacother; 2017 Jun 13; 90():705-712. PubMed ID: 28419966
    [Abstract] [Full Text] [Related]

  • 5. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H, Liu Q, Tang J, Xie Y, Xu X, Huang R, Zhang Y, Jin K, Sun B.
    Cell Physiol Biochem; 2017 Jun 13; 41(6):2289-2306. PubMed ID: 28456796
    [Abstract] [Full Text] [Related]

  • 6. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.
    Chen H, Wang H, Yu X, Zhou S, Zhang Y, Wang Z, Huang S, Wang Z.
    BMC Cancer; 2020 Sep 05; 20(1):853. PubMed ID: 32891122
    [Abstract] [Full Text] [Related]

  • 7. H Long Terminal Repeat-Associating 2 (HHLA2) is a Biomarker of Advanced Stage Hepatocellular Carcinoma and Promotes Tumor Cell Development In Vitro.
    Luo M, Xiong Y, Lin Y, Liang R, Li Y, Ge L.
    Med Sci Monit; 2021 May 15; 27():e930215. PubMed ID: 33990536
    [Abstract] [Full Text] [Related]

  • 8. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma.
    Liu C, Peng X, Li Y, Liu S, Hou R, Zhang Y, Zuo S, Liu Z, Luo R, Li L, Fang W.
    Biomed Pharmacother; 2020 Mar 15; 123():109780. PubMed ID: 31901550
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
    Song XZ, Ren XN, Xu XJ, Ruan XX, Wang YL, Yao TT.
    Technol Cancer Res Treat; 2020 Mar 15; 19():1533033820957023. PubMed ID: 32910747
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner.
    Li H, Lan T, Xu L, Liu H, Wang J, Li J, Chen X, Huang J, Li X, Yuan K, Zeng Y, Wu H.
    J Exp Clin Cancer Res; 2020 Jul 06; 39(1):128. PubMed ID: 32631394
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
    Yang YF, Zhang MF, Tian QH, Fu J, Yang X, Zhang CZ, Yang H.
    Mol Cancer; 2018 Aug 08; 17(1):117. PubMed ID: 30089483
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Curzerene suppresses hepatocellular carcinoma progression through the PI3K/AKT/MTOR pathway.
    Luo Y, Wang Z, Jiang J, Wu S, Zhai Y.
    Rev Invest Clin; 2024 Jul 24; 76(4):173-184. PubMed ID: 39047236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.